[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-362332-105":59,"doc-detail-362332-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","advances-in-isolation-and-detection-technologies-and-immunotherapy-applications-of-circulating-tumor-cells-review","Advances in isolation and detection technologies and immunotherapy applications of circulating tumor cells - Review","","Circulating tumor cells (CTCs) are released from primary tumors into peripheral blood, where they drive metastasis and recurrence. As a key component of liquid biopsy, CTCs support early tumor diagnosis, monitoring of therapeutic response, and prognosis. Their extreme rarity and biological heterogeneity, however, create major obstacles to isolation and enrichment, and limit predictive value in tumor immunotherapy. This review summarizes progress in CTC isolation and detection, links technologies to immunotherapy applications, and outlines challenges with future improvement strategies.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/advances-in-isolation-and-detection-technologies-and-immunotherapy-applications-of-circulating-tumor-cells-review/362332/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/advances-in-isolation-and-detection-technologies-and-immunotherapy-applications-of-circulating-tumor-cells-review/362332.png","ImageObject",300,407,{"name":92,"@type":93},"Ophelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What are circulating tumor cells (CTCs) and why are they important?","Question",{"text":113,"@type":114},"CTCs are tumor cells shed from primary tumors or metastatic sites into peripheral blood. They play crucial roles in metastasis and recurrence and offer major value for liquid biopsy.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What are the main challenges in isolating and enriching CTCs?",{"text":118,"@type":114},"CTCs are rare and highly heterogeneous, which makes isolation and enrichment technically difficult and limits consistent clinical performance.",{"name":120,"@type":111,"acceptedAnswer":121},"How does CTC technology connect to immunotherapy?",{"text":122,"@type":114},"The review describes how recent isolation and detection technologies can be used in clinical immunotherapy settings, while also discussing remaining limitations and future strategies to improve predictive usefulness.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},362332,1790471344,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","ONCOLOGY REPORTS 55: 57, 2026  \nAdvances in isolation and detection technologies and immunotherapy applications of circulating tumor cells (Review)  \nPING ZHOU 1* , QIN YE 1* , YIYUN HUANG 1 , YUMEI FENG 1 , LI ZHOU2 and KE XIE 1  \n1  \nDepartment of Oncology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan 610054, P.R. China; 2Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University, Chongqing 400016, P.R. China  \nReceived July 14, 2025; Accepted January 13, 2026  \nDOI: 10. 3892/or.2026.9062  \nAbstract. Circulating tumor cells (CTCs) are shed from the primary tumor into the peripheral bloodstream, where they play crucial roles in tumor metastasis and recurrence. As a cornerstone of liquid biopsy, CTCs hold significant potential for early tumor diagnosis, therapeutic response monitoring, and prognosis . However, the rarity and heterogeneity of CTCs pose considerable challenges for their isolation and  \nCorrespondence to: Professor Ke Xie, Department of Oncology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Section 2, 4 Jianshe North Road, Chenghua, Chengdu, Sichuan 610054, P.R. China  \nE‑[mail: mei97@sina.com](mail: mei97@sina.com)  \nProfessor Li Zhou, Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University, 1 Medical College Road, Yuzhong, Chongqing 400016, P.R. China  \nE‑mail: [lizhou802@cqmu.edu.cn](lizhou802@cqmu.edu.cn)  \n*Contributed equally  \nAbbreviations: CTCs, circulating tumor cells; PFS, progression‑free survival; OS, overall survival; FDA, U.S. Food and Drug Administration; EpCAMs, epithelial cell adhesion molecules; ISET, isolation by size of epithelial tumor cell; DEPArray, dielectrophoretic array; MAP, magnetophoretic; DEP, dielectrophoretic; MFM, multi‑flow microfluidic; CKs, cytokeratins; HER2, human epidermal growth factor receptor 2; EGFR, epithelial growth factor receptor; DLD, deterministic lateral displacement; EMT, epithelial‑mesenchymal transition; CNFs, cellulose nanofibers; NGS, next‑generation sequencing; FISH, fluorescence in situ hybridization; PD‑1, programmed cell death protein 1; PD‑L1, programmed cell death ligand 1; NSCLC, non‑small cell lung cancer; OS, overall survival; ICI, immune checkpoint inhibitor; PFS, progression‑free survival; LUAD, lung adenocarcinoma; OXA, oxaliplatin; MBC, metastatic breast cancer  \nKey words: CTCs, isolation, detection, immunotherapy  \nenrichment. Additionally, their predictive usefulness in tumor immunotherapy remains relatively limited. The present review summarizes recent advancements in CTC isolation and detection technologies, explores their clinical applications in immunotherapy, and discusses current challenges alongside potential strategies for improvement . The integration of these technologies into clinical practice could pave the way for more personalized and precise cancer treatment strategies in the future.  \nContents  \n1. Introduction  \n2. CTC enrichment technology  \n3. CTC detection methods  \n4. Clinical applications of CTCs in immunotherapy  \n5. Conclusions and perspectives  \n1. Introduction  \nCancer remains one of the most serious diseases that threaten human health, with metastasis being the leading cause of cancer‑related deaths worldwide and posing a major challenge in cancer treatment (1,2) . Metastasis is a complex process involving multiple steps (3), including intravasation, extrava‑ sation, migration and regeneration. During metastasis, tumor cells from the primary site invade distant tissues through the bloodstream, where they form metastatic foci (4) . In recent years, the prevailing view has been that metastatic disease is usually extensive and incurable . However, the advent of immunotherapy has led to significant breakthroughs in cancer treatment. When combined with surge","cbCaijzOoobTMcKU","https://ap.wps.com/l/cbCaijzOoobTMcKU","pdf",3770672,13,"English","# Contents\n## Introduction\n## CTC enrichment technology\n## CTC detection methods\n## Clinical applications of CTCs in immunotherapy\n## Conclusions and perspectives","[{\"question\":\"What are circulating tumor cells (CTCs) and why are they important?\",\"answer\":\"CTCs are tumor cells shed from primary tumors or metastatic sites into peripheral blood. They play crucial roles in metastasis and recurrence and offer major value for liquid biopsy.\"},{\"question\":\"What are the main challenges in isolating and enriching CTCs?\",\"answer\":\"CTCs are rare and highly heterogeneous, which makes isolation and enrichment technically difficult and limits consistent clinical performance.\"},{\"question\":\"How does CTC technology connect to immunotherapy?\",\"answer\":\"The review describes how recent isolation and detection technologies can be used in clinical immunotherapy settings, while also discussing remaining limitations and future strategies to improve predictive usefulness.\"}]","Advances in isolation and detection technologies and immunotherapy applications of circulating tumor cells - Review | PDF",1790147157,33,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f260c617718794d839605b5aa32d918f.webp",983,1357,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0673dcd470f005a474c5a660124c83ee.webp",982,1356,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ef19296b546f38c2a23056f13525169d.webp",981,1354,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d09bf091c9398b88ba9d18275e8bd34a.webp",980,1353]